Esperion Therapeutics Inc (ESPR)

44.34
NASDAQ : Health Care
Prev Close 42.31
Day Low/High 41.42 / 44.54
52 Wk Low/High 9.40 / 48.21
Avg Volume 809.30K
Exchange NASDAQ
Shares Outstanding 22.59M
Market Cap 955.78M
EPS -3.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Apple Could Explode Higher to $200 a Share If This Chart Pattern Is Correct

Apple Could Explode Higher to $200 a Share If This Chart Pattern Is Correct

Huge profits could be on the doorstep for these hot breakout setups.

ESPR Crosses Above Average Analyst Target

In recent trading, shares of Esperion Therapeutics Inc have crossed above the average analyst 12-month target price of $36.25, changing hands for $36.51/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Alibaba, Coherent, Advanced Micro Devices: 'Mad Money' Lightning Round

Alibaba, Coherent, Advanced Micro Devices: 'Mad Money' Lightning Round

Jim Cramer is bullish on Alibaba and Coherent; but he's bearish on Esperion Therapeutics.

These Sleeper Stocks Are Soaring: Cramer's 'Mad Money' Recap (Monday 4/10/17)

These Sleeper Stocks Are Soaring: Cramer's 'Mad Money' Recap (Monday 4/10/17)

Jim Cramer calls out the greatest American companies you probably never even think about.

ESPR Crosses Above Average Analyst Target

In recent trading, shares of Esperion Therapeutics Inc have crossed above the average analyst 12-month target price of $36.25, changing hands for $36.79/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Biotech Premarket Movers: Esperion, Minerva and BioCryst

Biotech Premarket Movers: Esperion, Minerva and BioCryst

Esperion Therapeutics, Minerva Neurosciences and BioCryst Pharmaceuticals were among the biotech stock movers in premarket trading on Tuesday.

How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More

How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More

Here's how to trade six of the most active names on the market this afternoon.

Biotechs Remain the Best Place For Stock Picking

Biotechs Remain the Best Place For Stock Picking

Biotech companies show more energy than the rest of the market Monday.

Biotech Premarket Movers: CytomX, Aevi, Esperion

Biotech Premarket Movers: CytomX, Aevi, Esperion

CytomX Therapeutics, Aevi Genomic Medicine and Esperion Therapeutics were among the biotech stock movers in premarket trading on Monday.

AveXis, Esperion and Amgen Among Biotech Movers

AveXis, Esperion and Amgen Among Biotech Movers

AveXis, Esperion Therapeutics, Medicines Co. and Amgen were among the biotech stock movers Friday morning.

PaylPal, CH Robinson Worldwide, Texas Instruments: 'Mad Money' Lightning Round

PaylPal, CH Robinson Worldwide, Texas Instruments: 'Mad Money' Lightning Round

Jim Cramer is bullish on PaylPal, CH Robinson Worldwide, Texas Instruments and NXP Semiconductors.

Here's Why Buffett Is So Bullish About This Market: Cramer's 'Mad Money' Recap (Monday 2/27/17)

Here's Why Buffett Is So Bullish About This Market: Cramer's 'Mad Money' Recap (Monday 2/27/17)

Jim Cramer highlight's Buffett's confidence in American businesses and stocks, and his critique of high fees charged by money managers.

First Week of April 21st Options Trading For Esperion Therapeutics

Investors in Esperion Therapeutics Inc saw new options become available this week, for the April 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ESPR options chain for the new April 21st contracts and identified one put and one call contract of particular interest.

Esperion Therapeutics Reaches Analyst Target Price

In recent trading, shares of Esperion Therapeutics Inc have crossed above the average analyst 12-month target price of $17.10, changing hands for $17.66/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Premarket Biotech Movers: Portola, Esperion, Medicines

Premarket Biotech Movers: Portola, Esperion, Medicines

Portola Pharmaceuticals, Esperion Therapeutics and Medicines were among the biotech stock movers in premarket trading on Friday.